Jiangsu Lanfeng Bio-chemical Co Ltd
Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers carbendazim, thiophanate-methyl, cycloazinone, carbosulfan butyl, sulfuric acid, and surfactant. Jiangsu Lanfeng Bio-chemical Co.,Ltd was founded in 1976 and is based in Xinyi, China.
Jiangsu Lanfeng Bio-chemical Co Ltd (002513) - Total Liabilities
Latest total liabilities as of September 2025: CN¥4.42 Billion CNY
Based on the latest financial reports, Jiangsu Lanfeng Bio-chemical Co Ltd (002513) has total liabilities worth CN¥4.42 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jiangsu Lanfeng Bio-chemical Co Ltd - Total Liabilities Trend (2007–2024)
This chart illustrates how Jiangsu Lanfeng Bio-chemical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jiangsu Lanfeng Bio-chemical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jiangsu Lanfeng Bio-chemical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Hongchang Electrical Technology Co. Ltd.
SHE:301008
|
China | CN¥694.38 Million |
|
Sichuan Haowu Electromechanical Co Ltd
SHE:000757
|
China | CN¥869.15 Million |
|
Jiangsu TongLin Electric Co.Ltd.
SHE:301168
|
China | CN¥1.23 Billion |
|
Berry Petroleum Corp
NASDAQ:BRY
|
USA | $748.02 Million |
|
Broedrene A&O Johansen A/S Series B
CO:AOJ-B
|
Denmark | Dkr2.54 Billion |
|
Zhejiang Shengda Pharm
SHG:603079
|
China | CN¥542.15 Million |
|
Lanzhou Minbai Shareholding Group Co Ltd
SHG:600738
|
China | CN¥1.11 Billion |
Liability Composition Analysis (2007–2024)
This chart breaks down Jiangsu Lanfeng Bio-chemical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -312.55 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.95 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jiangsu Lanfeng Bio-chemical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jiangsu Lanfeng Bio-chemical Co Ltd (2007–2024)
The table below shows the annual total liabilities of Jiangsu Lanfeng Bio-chemical Co Ltd from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥3.11 Billion | -1.36% |
| 2023-12-31 | CN¥3.15 Billion | +181.67% |
| 2022-12-31 | CN¥1.12 Billion | +5.34% |
| 2021-12-31 | CN¥1.06 Billion | -7.80% |
| 2020-12-31 | CN¥1.15 Billion | -26.55% |
| 2019-12-31 | CN¥1.57 Billion | -16.17% |
| 2018-12-31 | CN¥1.87 Billion | +24.72% |
| 2017-12-31 | CN¥1.50 Billion | -2.60% |
| 2016-12-31 | CN¥1.54 Billion | -5.37% |
| 2015-12-31 | CN¥1.63 Billion | +11.25% |
| 2014-12-31 | CN¥1.46 Billion | +4.28% |
| 2013-12-31 | CN¥1.40 Billion | +21.93% |
| 2012-12-31 | CN¥1.15 Billion | +87.87% |
| 2011-12-31 | CN¥612.09 Million | +6.06% |
| 2010-12-31 | CN¥577.14 Million | +40.21% |
| 2009-12-31 | CN¥411.64 Million | +46.63% |
| 2008-12-31 | CN¥280.73 Million | -7.26% |
| 2007-12-31 | CN¥302.71 Million | -- |